New AI Toolkit is the 'Scientist that never Sleeps'

Researchers have developed a new AI-driven platform that can analyse how pathogens infect our cells with the precision of a trained biologist. The platform, HRMAn ('Herman'), which stands for Host Response to Microbe Analysis, is open-source, easy-to-use and can be tailored for different pathogens including Salmonella enterica.

Pioneered by scientists at the Francis Crick Institute and UCL, HRMAn uses deep neural networks to analyse complex patterns in images of pathogen and human ('host') cell interactions, pulling out the same detailed characteristics that scientists do by-hand. The research is published in the open access journal eLife, which includes a link to download the platform and access tutorial videos.

"What used to be a manual, time-consuming task for biologists now takes us a matter of minutes on a computer, enabling us to learn more about infectious pathogens and how our bodies respond to them, more quickly and more precisely," says Eva Frickel, Group Leader at the Crick, who led the project. "HRMAn can actually see host-pathogen interactions like a biologist, but unlike us, it doesn't get tired and need to sleep!"

To demonstrate the power of HRMAn - which runs on the KNIME platform - the team used it to analyse the body's response to Toxoplasma gondii, a parasite that replicates in cats and is thought to be carried by more than a third of the world's population.

Researchers in the Crick's High Throughput Screening facility collected over 30,000 microscope images of five different types of Toxoplasma-infected human cells and loaded them into HRMAn for analysis. HRMAn detected and analysed over 175,000 pathogen-containing cellular compartments, providing detailed information about the number of parasites per cell, the location of the parasites within the cells, and how many cell proteins interacted with the parasites, among other variables.

"Previous attempts at automating host-pathogen image analysis failed to capture this level of detail," says Artur Yakimovich, Research Associate in Jason Mercer's lab at the MRC LMCB at UCL and co-first author of the study. "Using the same sorts of algorithms that run self-driving cars, we've created a platform that boosts the precision of high volume biological data analysis, which has revolutionised what we can do in the lab. AI algorithms come in handy when the platform evaluates the image-based data in a way a trained specialist would. It's also really easy to use, even for scientists with little to no knowledge of coding."

The team also used HRMAn to analyse Salmonella enterica - a bacterial pathogen 16 times smaller than Toxoplasma, demonstrating its versatility for studying different pathogens.

"Our team uses HRMAn to answer specific questions about host-pathogen interactions, but it has far-reaching implications outside the field too," says Daniel Fisch, Crick PhD student and co-first author of the study. "HRMAn can analyse any fluorescence image, making it relevant for lots of different areas of biology, including cancer research."

Daniel Fisch, Artur Yakimovich, Barbara Clough, Joseph Wright, Monique Bunyan, Michael Howell, Jason Mercer, Eva Frickel.
Defining host–pathogen interactions employing an artificial intelligence workflow.
eLife 2019;8:e40560. doi: 10.7554/eLife.40560.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...